Fundraising Fox

Cycad Group LLC

Venture capital

Santa Barbara · Seed–Late Stage · 4 people tracked

Fox Verdict
Sign up to see your fit

Investment thesis

Cycad Group is an opportunistic venture capital investor that does not restrict itself to a single industry, though it actively targets life sciences (therapeutics, medical devices, diagnostics and analytical tools), energy technologies, and advanced materials and chemical processes. The firm invests across all stages of company development, from a company's first round of outside financing through to PIPE transactions. At each stage, Cycad focuses on understanding the fundamental questions surrounding a company's technology, market opportunity, management team and risks before committing capital.

Source: firm website, verified Aug 3, 2026.

Stage
Seed–Late Stage
HQ
Santa Barbara, California, US
Leads rounds
Leads
Instruments
Equity
Founded
2000
Tracked investments
29

Team · 4 people

from the firm's website & public directories

What they invest in

from 12 of 29 portfolio companies

Biotech ×8Healthtech ×4Hardware ×3Cleantech ×2Energy ×2Medical Devices ×2

HQs:United States×14

Investments · 29 tracked

founders shown can be your intro path

By year:2016 · 12015 · 45 dated

Ziopharm OncologyNASDAQ: TCRT

BiotechBoston, US

Kevin Lafond(Executive Officer)Caesar Belbel(Executive Officer)Jonathan Lewis(Executive Officer, Director)

BoardRandal Kirk(Director)Timothy McInerney(Director)Michael Weiser(Director)

Advanced Bionicsadvancedbionics.comin𝕏

Advanced Bionics manufactures cochlear implant technology and sound processors for adults and children with severe hearing loss, including devices that connect to a telehealth app and integrate with Phonak hearing aids for bimodal solutions.

HardwareHealthtechMedical Devices

Agile RF

Goleta, US

Thomas Goodwin(President)

BoardK. Leonard Judson(Director)Robert Balch(Director)

Alsius
CalimmuneMay 2015

BiotechTucson, US

Louis Breton(Executive Officer, Director)David Baltimore, Ph.D.(Director)Bhavin Raval(Executive Officer)

BoardPeter Kolchinsky(Director)inJon Faiz Kayyem, Ph.D.(Director)Harry A. George(Director)

Co-investorsRA CapitalAlexandria

CDTI
Centaur Renovis
ClarVista MedicalApr 2015

HealthtechAliso Viejo, US

McLean Paul(Executive Officer, Director)

BoardCynthia Yee(Director)Behbahani Ali(Director)Robert Balch(Director)

Co-investorsNew Enterprise Associates (NEA)

ExThera Medicalextheramedical.com

BiotechHealthtechMartinez, US

Michael DiMeo(Executive Officer)Erin Borger(Executive Officer, Director)Robert S. Ward(Executive Officer, Director)Keith McCrea(Executive Officer, Director)George Pitarra(Executive Officer, Director)Kathleen White(Executive Officer)

Co-investorsFresenius Medical Care Ventures

First American Nuclear Co (FANCO)
Formetrix
Fziomedfziomed.cominSep 2015

FzioMed develops surgical barrier products designed to reduce the formation of postsurgical adhesions, which can cause complications after surgery.

BiotechHealthtechMedical DevicesSan Luis Obispo, US

John Krelle(Executive Officer, Director)

BoardRonald F. Haynes(Director)Kevin K. Sidow(Director)Tracy Augustine(Director)Daniel R. Doiron(Director)James R. Peters(Director)

Genocea Biosciences

Uses a T-cell antigen discovery platform to develop vaccines for oncology and infectious disease.

BiotechCambridge, US

Narinder Singh(Executive Officer)Derek Meisner(Executive Officer)Michael Alfieri(Executive Officer)Jessica Flechtner(Executive Officer)Girish Aakalu(Executive Officer)Thomas Davis(Executive Officer)

Co-investorsLux CapitalMC Healthcare VenturesAdvent Life SciencesNew Enterprise Associates (NEA)

GRT, Inc.
ImaginAb
Intarcia TherapeuticsDec 2016

Biopharmaceutical company developing innovative therapies for chronic diseases using proprietary drug delivery systems.

BiotechBoston, US

James Ahlers(Executive Officer)John Yee(Executive Officer)Sunita Zalani(Executive Officer)Raymond T. Keane(Executive Officer)Thomas Alessi(Executive Officer)Owen Hughes, Jr.(Executive Officer)

Co-investorsBay City CapitalForesite CapitalNXT Ventures

Lixivialixivia-inc.com

Santa Barbara, US

Michael Wyrsta(Executive Officer, Director)

BoardK. Leonard Judson(Director)Zachary Komon(Director)

Nanosteel

Providence, US

David Paratore(Executive Officer, Director)

BoardOlivier Perier(Director)Eric Kerr(Director)Scott Ungerer(Director)inJames Goldinger(Director)Richard Mackellar(Director)

Co-investorsEnerTech Capital

Ovascience

Co-investorsBessemer Venture Partners

Sirtris Pharmaceuticals

Co-investorsBessemer Venture Partners

Sofie
Sofie Biosciencessofiebio.comin𝕏

BiotechCulver City, US

Michael Phelps(Director)Stan Berman(Executive Officer)Patrick Phelps(Executive Officer, Director)Johannes Czernin(Director)James Heath(Director)

BoardAjit Singh(Director)

Solariasolaria.comin𝕏

Solaria is a solar panel product line whose warranty services are now administered by SunPower, Inc. (formerly Complete Solaria, Inc.).

CleantechEnergyHardwareFremont, US

Suvi Sharma(Executive Officer, Director)Robert Zapotosky(Executive Officer)Daniel Shugar(Director)

BoardLi Biao(Director)Bang Nguyen(Director)Wu Binyan(Director)

Co-investorsDBL PartnersAdams Street Partners

SSC Universal Space Network
Sterifx
TPX
Unity Biotechnologyunitybiotechnology.cominDefunct

Unity Biotechnology was a biotechnology company that is no longer operating.

BiotechBrisbane, US

Dan Marquess(Executive Officer)Keith Leonard(Executive Officer, Director)Tamara Tompkins(Executive Officer)Bob Goeltz(Executive Officer)Camille Samuels(Director)Jamie Dananberg(Executive Officer)

Co-investorsage1ARCH Venture PartnersEcoR1 CapitalKhosla VenturesVenrock

Urban Electric Powerurbanelectricpower.comin𝕏Sep 2015

Urban Electric Power manufactures modular, rechargeable zinc-based battery energy storage systems for commercial, industrial, and off-grid applications.

CleantechEnergyHardwarePearl River, US

Alexander Couzis(Executive Officer, Director)Sanjoy Banerjee(Director)Ann Marie Scuderi(Executive Officer)Thomas R Baruch(Director)

BoardDavid Elliman(Director)Jamshyd Godrej(Director)

Co-investorsBaruch Future Ventures

Visterraacquired by Otsuka

Hierotope platform for precision biologics; acquired by Otsuka.

Co-investorsCTI Life Sciences Fund L.P.Lux CapitalMRL Ventures Fund

Exits · 2

IPOs and acquisitions across the tracked portfolio

Ziopharm OncologyNASDAQ: TCRTVisterraacq. by Otsuka

Portfolio news

latest coverage across their companies

Frequently asked questions

How many investments has Cycad Group LLC made?
Cycad Group LLC has 29 tracked investments, 1 of which have exited via acquisition or IPO.
What stage does Cycad Group LLC invest at?
Cycad Group LLC invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
What sectors does Cycad Group LLC focus on?
Cycad Group LLC focuses on Biotech, Deep Tech, Energy, Medical Devices, New Materials, Sector Agnostic, Space Tech.
Where is Cycad Group LLC located?
Cycad Group LLC is headquartered in Santa Barbara, US.
Does Cycad Group LLC lead rounds?
Yes, Cycad Group LLC leads investment rounds.
Who does Cycad Group LLC co-invest with?
Cycad Group LLC most often shares deals with Bessemer Venture Partners, Lux Capital, Khosla Ventures, among 18 tracked co-investors.

Similar investors

Featured in lists